Skip to main content
. 2022 Feb 10;17:32. doi: 10.1186/s13014-022-02001-w

Table 4.

Recurrence pattern according to each clinical feature

Anterior peripancreatic invasion Tumor location
Variables n (%) Positive (n = 104) Negative (n = 19) P value Head (n = 59) Body-Tail (n = 64) P value
Local progression, n (%) 0.555 0.275
 Yes 32 (26) 26 (25) 6 (32) 18 (31) 14 (22)
 No 91 (74) 78 (75) 13 (68) 41 (69) 50 (78)
Local progression within 6 months, n (%) 0.119 0.780
 Yes 7 (6) 7 (7) 0 (0) 3 (5) 4 (6)
 No 116 (94) 97 (93) 19 (100) 56 (95) 60 (94)
Local progression within 1 year, n (%) 0.568 0.084
 Yes 18 (15) 16 (15) 2 (11) 12 (20) 6 (9)
 No 105 (85) 88 (859 17 (89) 47 (80) 58 (91)
Distant metastasis, n (%) 0.026 0.853
 Yes 74 (60) 67 (64) 7 (37) 36 (61) 38 (59)
 No 49 (40) 37 (36) 12 (63) 23 (39) 26 (41)
Liver metastasis within 6 months, n (%) 0.066 0.988
 Yes 23 (19) 22 (21) 1 (5) 11 (19) 12 (19)
 No 100 (81) 82 (79) 18 (95) 48 (81) 52 (81)
Liver metastasis within 1 year, n (%) 0.099 0.870
 Yes 30 (24) 28 (27) 2 (11) 14 (24) 16 (25)
 No 99 (76) 76 (73) 17 (89) 45 (76) 48 (75)
Peritoneal dissemination within 6 months, n (%) 0.039 0.882
 Yes 12 (10) 12 (12) 0 (0) 6 (10) 6 (9)
 No 111 (90) 92 (88) 19 (100) 53 (90) 58 (91)
Peritoneal dissemination within 1 year, n (%) 0.584 0.656
 Yes 25 (20) 22 (21) 3 (16) 11 (19) 14 (22)
 No 98 (80) 82 (79) 16 (84) 48 (81) 50 (78)

Significant P values (< 0.05) are in bold